Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ester Fonsatti

Showing results (1-10 of 44) with videos related to

Pageof 5
Sort By:
Journal of Translational Medicine|June 15, 2004
Highlights on endoglin (CD105): from basic findings towards clinical applications in human cancerEster Fonsatti, Michele Maio
Cardiovascular Research|February 2, 2006
Is it the primetime for endoglin (CD105) in the clinical setting?Michele Maio, Maresa Altomonte, Ester Fonsatti
Tumori|June 21, 2008
The Italian Network for Tumor Biotherapy (NIBIT). Sharing visions, goals and efforts at European levelMichele Maio, Ester Fonsatti, Arianna Burigo, et al.
Journal of Translational Medicine|June 29, 2004
Optimizing complement-activating antibody-based cancer immunotherapy: a feasible strategy?Ester Fonsatti, Anna Maria Di Giacomo, Michele Maio
Oncogene|October 7, 2003
Targeted therapy of solid malignancies via HLA class II antigens: a new biotherapeutic approach?Maresa Altomonte, Ester Fonsatti, Alberto Visintin, et al.
Seminars in Oncology|November 16, 2010
Biology and clinical applications of CD40 in cancer treatmentEster Fonsatti, Michele Maio, Maresa Altomonte, et al.
Seminars in Oncology|May 13, 2015
Immunologic correlates in the course of treatment with immunomodulating antibodiesBenjamin Weide, Anna Maria Di Giacomo, Ester Fonsatti, et al.
International Journal of Cancer|April 22, 2003
Methylation-regulated expression of HLA class I antigens in melanomaEster Fonsatti, Luca Sigalotti, Sandra Coral, et al.
Cancer Immunology, Immunotherapy : CII|July 5, 2014
"Cancer Bio-Immunotherapy in Siena": Eleventh Meeting of the Network Italiano per la Bioterapia dei Tumori (NIBIT), Siena, Italy, October 17-19, 2013Michele Maio, Hugues Jean Marie Nicolay, Ornella Cutaia, et al.
Oncogene|October 7, 2003
Endoglin (CD105): a powerful therapeutic target on tumor-associated angiogenetic blood vesselsEster Fonsatti, Maresa Altomonte, Maria Rita Nicotra, et al.
Pageof 5

Showing results (1-10 of 44) with videos related to

Sort By:
Pageof 5
Journal of Translational Medicine|June 15, 2004
Highlights on endoglin (CD105): from basic findings towards clinical applications in human cancerEster Fonsatti, Michele Maio
Cardiovascular Research|February 2, 2006
Is it the primetime for endoglin (CD105) in the clinical setting?Michele Maio, Maresa Altomonte, Ester Fonsatti
Tumori|June 21, 2008
The Italian Network for Tumor Biotherapy (NIBIT). Sharing visions, goals and efforts at European levelMichele Maio, Ester Fonsatti, Arianna Burigo, et al.
Journal of Translational Medicine|June 29, 2004
Optimizing complement-activating antibody-based cancer immunotherapy: a feasible strategy?Ester Fonsatti, Anna Maria Di Giacomo, Michele Maio
Oncogene|October 7, 2003
Targeted therapy of solid malignancies via HLA class II antigens: a new biotherapeutic approach?Maresa Altomonte, Ester Fonsatti, Alberto Visintin, et al.
Seminars in Oncology|November 16, 2010
Biology and clinical applications of CD40 in cancer treatmentEster Fonsatti, Michele Maio, Maresa Altomonte, et al.
Seminars in Oncology|May 13, 2015
Immunologic correlates in the course of treatment with immunomodulating antibodiesBenjamin Weide, Anna Maria Di Giacomo, Ester Fonsatti, et al.
International Journal of Cancer|April 22, 2003
Methylation-regulated expression of HLA class I antigens in melanomaEster Fonsatti, Luca Sigalotti, Sandra Coral, et al.
Cancer Immunology, Immunotherapy : CII|July 5, 2014
"Cancer Bio-Immunotherapy in Siena": Eleventh Meeting of the Network Italiano per la Bioterapia dei Tumori (NIBIT), Siena, Italy, October 17-19, 2013Michele Maio, Hugues Jean Marie Nicolay, Ornella Cutaia, et al.
Oncogene|October 7, 2003
Endoglin (CD105): a powerful therapeutic target on tumor-associated angiogenetic blood vesselsEster Fonsatti, Maresa Altomonte, Maria Rita Nicotra, et al.
Pageof 5